Asthma

News

Gaps in follow-up care put kids with asthma at risk of severe recurrence

Author:

Tara Haelle

Publish date: April 13, 2022

Dr. Bardach’s group estimated that, for every 30 children who have follow-up visits with a physician, one would avoid a return trip to the ED for...

• Read More

News

Obesity linked to combined OSA syndrome and severe asthma

Author:

Heidi Splete

Publish date: March 18, 2022

Other independent factors associated with OSAS included male sex, high blood pressure, depression, and late-...

• Read More

News

Dealing with life-threatening asthma attacks

Author:

Pam Harrison

Publish date: March 17, 2022

“If these exacerbations do not resolve within 24 to 48 hours, clinicians need to start thinking, ‘This could be...

• Read More

News

FDA approves generic Symbicort for asthma, COPD

Author:

Mark S. Lesney, PhD

Publish date: March 16, 2022

The approval was given for a metered-dose inhaler that contains both budesonide and formoterol.

• Read More

News

Digital monitors can relieve asthma burden by boosting medication adherence and inhaler technique

Author:

Esther Landhuis

Publish date: March 15, 2022

From 1975 to 2014, despite new devices and new technologies, “we still have poor inhaler technique.”

• Read More

News

Asthma: Easy strategy reduces exacerbations, improves control

Author:

Esther Landhuis

Publish date: March 3, 2022

An inexpensive intervention that can be explained in a single office visit reduced severe exacerbations and...

• Read More

News

FDA approves tezepelumab-ekko (Tezspire) for severe asthma

Author:

Mark S. Lesney, PhD

Publish date: December 20, 2021

“Tezspire represents a much-needed new treatment for the many patients who remain underserved and continue to struggle with severe, uncontrolled...

• Read More

News

Itepekimab reduces loss of asthma control

Author:

Walter Alexander, MS

Publish date: October 28, 2021

At 12 weeks, the itepekimab and dupilumab monotherapy groups but not the combination group revealed a lower rate...

• Read More

News

Placebo beat risankizumab in adults with severe asthma

Author:

Walter Alexander

Publish date: October 28, 2021

Placebo was superior to risankizumab with respect to time to first asthma worsening and annualized rate of...

• Read More

News

Dupilumab-improved lung function lasts in children with moderate to severe asthma

Author:

Andrew D. Bowser

Publish date: October 18, 2021

Add-on treatment yielded significant improvements over 52 weeks in children with the type 2 phenotype, the most...

• Read More

Pages

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• last »